|
|
|
|
|
|
|
|
|
|
Previous: GENETRONICS BIOMEDICAL LTD, 10-Q, EX-10.2, 2000-08-14 |
Next: BVF PARTNERS L P/IL, 13F-NT, 2000-08-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> MAR-31-2001
<PERIOD-START> APR-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 8,253,460
<SECURITIES> 0
<RECEIVABLES> 999,316
<ALLOWANCES> 29,927
<INVENTORY> 837,316
<CURRENT-ASSETS> 10,289,873
<PP&E> 2,228,869
<DEPRECIATION> 1,240,212
<TOTAL-ASSETS> 12,711,993
<CURRENT-LIABILITIES> 1,956,145
<BONDS> 0
0
0
<COMMON> 42,258,240
<OTHER-SE> (31,571,620)
<TOTAL-LIABILITY-AND-EQUITY> 12,711,993
<SALES> 1,164,788
<TOTAL-REVENUES> 1,390,554
<CGS> 454,640
<TOTAL-COSTS> 454,640
<OTHER-EXPENSES> 2,843,194
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 5,076
<INCOME-PRETAX> (1,907,280)
<INCOME-TAX> 0
<INCOME-CONTINUING> (1,907,280)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (1,907,280)
<EPS-BASIC> (0.08)
<EPS-DILUTED> (0.08)
</TABLE>
|
|